Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.168 Q1 | 103 | 156 | 307 | 20941 | 1976 | 293 | 5.03 | 134.24 | 43.51 | |
2 | Current Vascular Pharmacology | journal | 0.917 Q1 | 69 | 60 | 187 | 4056 | 722 | 153 | 3.99 | 67.60 | 34.87 | |
3 | Current Medicinal Chemistry | journal | 0.776 Q2 | 202 | 335 | 1214 | 38296 | 5236 | 1130 | 3.90 | 114.32 | 43.21 | |
4 | Current Molecular Pharmacology | journal | 0.694 Q2 | 49 | 71 | 166 | 7930 | 517 | 157 | 2.67 | 111.69 | 45.19 | |
5 | Current Cancer Drug Targets | journal | 0.687 Q2 | 103 | 69 | 228 | 5875 | 726 | 219 | 2.97 | 85.14 | 41.03 | |
6 | Current Drug Targets | journal | 0.621 Q2 | 119 | 110 | 419 | 12345 | 1457 | 403 | 3.15 | 112.23 | 37.65 | |
7 | Journal of Toxicology | journal | 0.614 Q2 | 47 | 39 | 86 | 2062 | 344 | 85 | 3.18 | 52.87 | 36.87 | |
8 | Current Pharmaceutical Design | journal | 0.580 Q2 | 183 | 329 | 1399 | 30311 | 4728 | 1281 | 3.02 | 92.13 | 39.21 | |
9 | CNS and Neurological Disorders - Drug Targets | journal | 0.574 Q2 | 96 | 81 | 217 | 8156 | 639 | 205 | 2.86 | 100.69 | 38.48 | |
10 | Mini-Reviews in Medicinal Chemistry | journal | 0.570 Q2 | 107 | 162 | 450 | 17321 | 1925 | 442 | 3.98 | 106.92 | 41.82 | |
11 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.428 Q3 | 108 | 286 | 635 | 21787 | 1751 | 622 | 2.76 | 76.18 | 45.09 | |
12 | Current Radiopharmaceuticals | journal | 0.379 Q3 | 32 | 38 | 99 | 1789 | 195 | 87 | 1.75 | 47.08 | 43.56 | |
13 | Reviews on Recent Clinical Trials | journal | 0.377 Q3 | 35 | 46 | 136 | 1902 | 226 | 119 | 1.60 | 41.35 | 41.61 | |
14 | Open Medicinal Chemistry Journal | journal | 0.352 Q3 | 23 | 6 | 22 | 464 | 50 | 19 | 2.75 | 77.33 | 46.67 | |
15 | Current Drug Safety | journal | 0.318 Q3 | 41 | 55 | 117 | 1784 | 173 | 113 | 1.51 | 32.44 | 49.03 | |
16 | Infectious Disorders - Drug Targets | journal | 0.298 Q3 | 61 | 100 | 328 | 4928 | 482 | 311 | 1.40 | 49.28 | 43.11 | |
17 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.280 Q3 | 27 | 18 | 87 | 1262 | 138 | 82 | 1.36 | 70.11 | 46.59 | |
18 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.270 Q3 | 45 | 29 | 106 | 1316 | 124 | 100 | 1.09 | 45.38 | 27.59 | |
19 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.268 Q3 | 43 | 26 | 55 | 1492 | 98 | 49 | 1.37 | 57.38 | 38.14 | |
20 | Anti-Infective Agents | journal | 0.159 Q4 | 26 | 44 | 125 | 2557 | 94 | 120 | 0.69 | 58.11 | 39.38 | |
21 | Arabian Journal of Medicinal and Aromatic Plants | journal | 0.141 Q4 | 5 | 28 | 62 | 1296 | 44 | 62 | 0.62 | 46.29 | 37.69 | |
22 | Bulletin of Pharmaceutical Sciences. Assiut | journal | 0.121 Q4 | 10 | 95 | 88 | 4009 | 24 | 88 | 0.28 | 42.20 | 52.80 | |
23 | Current Pharmacogenomics and Personalized Medicine | journal | 0.110 Q4 | 20 | 12 | 37 | 381 | 9 | 32 | 0.24 | 31.75 | 58.54 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®